Stock Options (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jan. 15, 2025 |
Jun. 30, 2026 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Number of options granted | 400,000 | |||
| Weighted average exercise prices granted | $ 11.50 | |||
| Stock-based compensation | $ 495,146 | $ 138,641 | $ 277,282 | $ 990,292 |
| Intrinsic value | $ 4,975,156 | $ 4,975,156 | ||
| Options exchanged | 11,875 | 73,250 | ||
| Cashless exercises | 8,264 | 54,890 | ||
| Vested stock options intrinsic value | $ 2,850,156 | $ 2,850,156 | ||
| Weighted average remaining term | 1 year 6 months | |||
| 2026 [Member] | ||||
| Description of stock based compensation | Future expense for this stock option grant will be $59,418 for each of the third and fourth quarters of 2026 | |||
| Stock Options [Member] | ||||
| options were exercised for cash | 4,500 | 22,000 | ||
| Intrinsic value of options exercised | $ 465,010 | $ 3,294,798 | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average period until annuitization or benefit payment is expected to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Change in the weighted average exercise price of options outstanding. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|